M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal ArticleDOI
Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines.
Tomoyuki Sakamoto,Yasuhito Tanaka,Etsuro Orito,Jonard Co,Joseph Clavio,Fuminaka Sugauchi,Kiyoaki Ito,Atsushi Ozasa,Alvin P. Quino,Ryuzo Ueda,Jose D. Sollano,Masashi Mizokami +11 more
TL;DR: Novel HBV subtypes (subgenotypes) C5 and B5 are prevalent in the Philippines, as well as HBV/Aa (A1), where such studies have not been carried out previously.
Journal ArticleDOI
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.
Carla Kuiken,Christophe Combet,Jens Bukh,Tadasu Shin-I,Gilbert Deléage,Masashi Mizokami,Russell Richardson,Erwin Sablon,Karina Yusim,Jean-Michel Pawlotsky,Peter Simmonds +10 more
TL;DR: A numbering system adapted from the Los Alamos HIV database with elements from the hepatitis B virus numbering system is proposed, which comprises both nucleotides and amino acid sequences and epitopes for HCV polyprotein and the untranslated regions.
Journal ArticleDOI
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.
Ken Shirabe,Yuki Bekki,Dolgormaa Gantumur,Kenichiro Araki,Norihiro Ishii,Atsushi Kuno,Hisashi Narimatsu,Masashi Mizokami +7 more
TL;DR: Mac 2-Binding Protein Gylcan Isomer is shown to be a surrogate marker for assessing HSC activation and may reveal the roles of HSCs in extrahepatic fibrotic disease progression, which is important for predicting the efficacy of antiviral therapy and patient prognosis.
Journal ArticleDOI
Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt
Niveen Saudy,Fuminaka Sugauchi,Yasuhito Tanaka,Seiji Suzuki,Amina Mostafa Abdel Aal,Mostafa Abo Zaid,Salah Agha,Masashi Mizokami +7 more
TL;DR: The results indicate that HBV genotypes D and HDV genotype I are most prevalent in Egypt, andHDV co‐infection in HBV carriers is related to severity of liver disease.
Journal ArticleDOI
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease.
Fuminaka Sugauchi,Tomoyoshi Ohno,Etsuro Orito,Hiroshi Sakugawa,Takafumi Ichida,Masafumi Komatsu,Tomoyuki Kuramitsu,Ryuzo Ueda,Yuzo Miyakawa,Masashi Mizokami +9 more
TL;DR: The results indicate that the development of preS deletion mutants depends on HBV genotypes and that it may be associated with progressive liver disease.